Literature DB >> 19880287

Common problems related to the use of number needed to treat.

Andreas Stang1, Charles Poole, Ralf Bender.   

Abstract

OBJECTIVE: To illustrate basic issues that have to be taken into account when study results are presented by means of the number needed to treat (NNT). STUDY DESIGN AND
SETTING: This article presents an overview of common problems related to the NNT with corresponding explanations.
RESULTS: Without stating the direction of the effect, the alternative treatment, the treatment period, and the follow-up period, information in terms of NNTs is uninterpretable. The naive use of person-time data for the calculation of NNTs is frequently inappropriate. Rounding NNTs to the next upward integer may obscure differences among therapies.
CONCLUSIONS: The basic information about which treatments are compared, the treatment period, the follow-up period, and the direction of the effect should be given when study results are presented in terms of NNTs. Adequate methods should be used for point and interval estimation of NNTs. Unnecessary rounding of NNTs should be avoided. In more complicated situations of confounding or varying follow-up times, the use of more sophisticated methods is required with increasing potential for misinterpretation. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19880287     DOI: 10.1016/j.jclinepi.2009.08.006

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  17 in total

1.  Impact of a Telephonic Intervention to Improve Diabetes Control on Health Care Utilization and Cost for Adults in South Bronx, New York.

Authors:  Bahman P Tabaei; Renata E Howland; Jeffrey S Gonzalez; Shadi Chamany; Elizabeth A Walker; Clyde B Schechter; Winfred Y Wu
Journal:  Diabetes Care       Date:  2020-03-04       Impact factor: 19.112

2.  Comparative effectiveness of postoperative chemotherapy among older patients with non-metastatic rectal cancer treated with preoperative chemoradiotherapy.

Authors:  Jennifer L Lund; Til Sturmer; Hanna K Sanoff
Journal:  J Geriatr Oncol       Date:  2016-02-23       Impact factor: 3.599

3.  From exposures to population interventions: pregnancy and response to HIV therapy.

Authors:  Daniel Westreich
Journal:  Am J Epidemiol       Date:  2014-02-25       Impact factor: 4.897

4.  The Interventional Effect Cannot Be Interpreted.

Authors:  Andreas Stang
Journal:  Dtsch Arztebl Int       Date:  2018-01-26       Impact factor: 5.594

5.  Beta-blockers in heart failure patients with severe chronic kidney disease-time for a randomized controlled trial?

Authors:  Rajiv Agarwal; Patrick Rossignol
Journal:  Nephrol Dial Transplant       Date:  2020-05-01       Impact factor: 5.992

6.  Combined effect of posttraumatic stress disorder and prescription opioid use on risk of cardiovascular disease.

Authors:  Jeffrey F Scherrer; Joanne Salas; Patrick Lustman; Peter Tuerk; Sarah Gebauer; Sonya B Norman; F David Schneider; Kathleen M Chard; Carissa van den Berk-Clark; Beth E Cohen; Paula P Schnurr
Journal:  Eur J Prev Cardiol       Date:  2019-05-13       Impact factor: 7.804

7.  Estimated effects of potential interventions to prevent decreases in self-rated health among breast cancer survivors.

Authors:  Mario Schootman; Anjali D Deshpande; Sandi Pruitt; Rebecca Aft; Donna B Jeffe
Journal:  Ann Epidemiol       Date:  2012-02       Impact factor: 3.797

8.  Using and Interpreting Adjusted NNT Measures in Biomedical Research.

Authors:  Ralf Bender
Journal:  Open Dent J       Date:  2010-07-16

9.  CHEMOPROPHYLAXIS TO CONTROL LEPROSY AND THE PERSPECTIVE OF ITS IMPLEMENTATION IN BRAZIL: A PRIMER FOR NON-EPIDEMIOLOGISTS.

Authors:  Sergio Souza da Cunha; Ana Luiza Bierrenbach; Vitor Hugo Lima Barreto
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015-12       Impact factor: 1.846

10.  Comparison of stratified primary care management for low back pain with current best practice (STarT Back): a randomised controlled trial.

Authors:  Jonathan C Hill; David G T Whitehurst; Martyn Lewis; Stirling Bryan; Kate M Dunn; Nadine E Foster; Kika Konstantinou; Chris J Main; Elizabeth Mason; Simon Somerville; Gail Sowden; Kanchan Vohora; Elaine M Hay
Journal:  Lancet       Date:  2011-09-28       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.